Russell Frank Company’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
$1.35M Sell
34,054
-19,304
-36% -$764K ﹤0.01% 2045
2015
Q4
$3.01M Buy
53,358
+5,148
+11% +$291K 0.01% 1580
2015
Q3
$1.92M Buy
48,210
+7,202
+18% +$287K ﹤0.01% 1864
2015
Q2
$1.96M Buy
41,008
+40,390
+6,536% +$1.93M ﹤0.01% 1984
2015
Q1
$25K Buy
+618
New +$25K ﹤0.01% 2867
2013
Q4
Sell
-8,230
Closed -$93K 2951
2013
Q3
$93K Sell
8,230
-156,260
-95% -$1.77M ﹤0.01% 2970
2013
Q2
$2.2M Buy
+164,490
New +$2.2M ﹤0.01% 1712